Jaqua Nathan T, Peterson Matthew R, Davis Karla L
Department of Internal Medicine, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI 96859, USA.
Case Rep Med. 2013;2013:610726. doi: 10.1155/2013/610726. Epub 2013 Mar 27.
A 24-year-old male Marine with an uncomplicated medical history and a long history of strenuous, daily exercise presented to the emergency department after experiencing anaphylactic shock while running. Symptoms resolved following administration of intramuscular diphenhydramine, ranitidine, intravenous methylprednisolone, and intravenous fluids. On followup in the allergy clinic, a meticulous clinical history was obtained which elucidated a picture consistent with exercise-induced anaphylaxis. He had experienced diffuse pruritus and urticaria while exercising on multiple occasions over the last three years. His symptoms would usually increase as exercise continued. Prior to the first episode, he regularly exercised without symptoms. Exercise-induced anaphylaxis is a rare but potentially life-threatening syndrome that requires a careful clinical history and is a diagnosis of exclusion. Treatment is primarily exercise avoidance. Prophylactic mediations are inconsistently effective but are empirically used. Successful treatment with omalizumab was recently reported in a case of refractory exercise-induced anaphylaxis.
一名24岁的男性海军陆战队队员,既往病史无异常,有长期每日剧烈运动的历史,在跑步时发生过敏性休克后被送往急诊科。给予肌肉注射苯海拉明、雷尼替丁、静脉注射甲泼尼龙和静脉输液后症状缓解。在过敏诊所随访时,详细询问了临床病史,结果显示符合运动诱发过敏反应的情况。在过去三年中,他多次在运动时出现全身瘙痒和荨麻疹。随着运动持续,他的症状通常会加重。在首次发作之前,他定期运动且没有症状。运动诱发过敏反应是一种罕见但可能危及生命的综合征,需要详细的临床病史,且是一种排除性诊断。主要治疗方法是避免运动。预防性药物治疗效果不一,但可凭经验使用。最近有报道称,一名难治性运动诱发过敏反应患者使用奥马珠单抗治疗成功。